These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 24907721)

  • 1. Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant.
    Bassil N; Rostaing L; Mengelle C; Kallab S; Esposito L; Guitard J; Cardeau-Desangles I; Weclawiak H; Izopet J; Kamar N
    Exp Clin Transplant; 2014 Jun; 12(3):212-9. PubMed ID: 24907721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JC virus DNA in the peripheral blood of renal transplant patients: a 1-year prospective follow-up in France.
    Mengelle C; Kamar N; Mansuy JM; Sandres-Sauné K; Legrand-Abravanel F; Miédougé M; Rostaing L; Izopet J
    J Med Virol; 2011 Jan; 83(1):132-6. PubMed ID: 21108350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of multiplex real-time PCR assays for rapid detection of cytomegalovirus, Epstein-Barr virus, and polyomavirus BK in whole blood from transplant candidates.
    Hwang KA; Ahn JH; Nam JH
    J Microbiol; 2018 Aug; 56(8):593-599. PubMed ID: 30047089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
    Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
    Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of a screening protocol for polyoma virus results in a decreased rate of opportunistic non-BK viral disease after renal transplantation.
    Koleilat I; Kushnir L; Gallichio M; Conti DJ
    Transpl Infect Dis; 2011 Feb; 13(1):1-8. PubMed ID: 20723175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients.
    Smith TF; Espy MJ; Mandrekar J; Jones MF; Cockerill FR; Patel R
    Clin Infect Dis; 2007 Oct; 45(8):1056-61. PubMed ID: 17879925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of posttransplant polyomavirus infection in renal transplant recipients.
    Hu J; Zhao H; Huang Y; Zhang X; Gao H; Yang M; Fan J; Ma W
    Exp Clin Transplant; 2011 Jun; 9(3):175-80. PubMed ID: 21649565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a transplant multiplex viral panel on the ICEPlex system with real-time PCR for detection of cytomegalovirus, Epstein-Barr virus, and BK virus in clinical specimens.
    Khare R; Espy MJ; Mandrekar JN; Binnicker MJ
    J Clin Microbiol; 2014 May; 52(5):1711-3. PubMed ID: 24554746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.
    Kroll JL; Beam C; Li S; Viscidi R; Dighero B; Cho A; Boulware D; Pescovitz M; Weinberg A;
    J Clin Virol; 2013 Jun; 57(2):115-9. PubMed ID: 23422292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of BK virus infection and nephropathy during the first year after kidney transplantation.
    Soleymanian T; Keyvani H; Jazayeri SM; Fazeli Z; Ghamari S; Mahabadi M; Chegeni V; Najafi I; Ganji MR
    Iran J Kidney Dis; 2014 Mar; 8(2):145-51. PubMed ID: 24685738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
    Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
    J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
    Mallat SG; Tanios BY; Itani HS; Lotfi T; McMullan C; Gabardi S; Akl EA; Azzi JR
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1321-1336. PubMed ID: 28576905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epstein-Barr virus and cytomegalovirus primary infections: a comparative study in 52 immunocompetent adults].
    Batalla AS; Benito D; Baumard S; Brodard V; Servettaz A; Jaussaud R; Strady C
    Med Mal Infect; 2011 Jan; 41(1):14-9. PubMed ID: 20832213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
    Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
    Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
    Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The simultaneous presence of active BK, Epstein Barr, and human cytomegalovirus infection and their correlation by host factors in patients suspected of kidney transplant rejection.
    Eslami Kojidi M; Shatizadeh Malekshahi S; Jabbari MR
    BMC Infect Dis; 2024 Sep; 24(1):937. PubMed ID: 39251898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies.
    Larsen CP; Grinyó J; Medina-Pestana J; Vanrenterghem Y; Vincenti F; Breshahan B; Campistol JM; Florman S; Rial Mdel C; Kamar N; Block A; Di Russo G; Lin CS; Garg P; Charpentier B
    Transplantation; 2010 Dec; 90(12):1528-35. PubMed ID: 21076381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes.
    Levi S; Davidovits M; Alfandari H; Dagan A; Borovitz Y; Bilavsky E; Landau D; Haskin O
    Pediatr Transplant; 2022 May; 26(3):e14199. PubMed ID: 34817112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
    Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
    Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.